Goldman Sachs
OCDX

Goldman Sachs’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Goldman Sachs’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,191,433
Closed -$40.9M – 6921
2022
Q1 		$40.9M Buy
2,191,433
+1,187,486
+118% +$21.4M 0.01% 1449
2021
Q4 		$21.5M Buy
1,003,947
+676,700
+207% +$13.3M ﹤0.01% 2053
2021
Q3 		$6.05M Buy
327,247
+264,162
+419% +$5.32M ﹤0.01% 3194
2021
Q2 		$1.35M Sell
63,085
-481,120
-88% -$9.78M ﹤0.01% 4537
2021
Q1 		$10.5M Buy
+544,205
New +$9.59M ﹤0.01% 2526

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Goldman Sachs's OCDX Position: Q2 2022 in Review

Goldman Sachs sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 2,191,433 shares — an estimated $40.9M sold.

Goldman Sachs first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $40.9M in Q1 2022. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Goldman Sachs reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Goldman Sachs sold 2,191,433 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $40.9M.
  • Goldman Sachs first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
  • Goldman Sachs's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $40.9M in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Goldman Sachs's 13F filing for Q2 2022, filed 15 Aug 2022.